A phase II trial of a house dust mite allergy immunotherapy in patients hypersensitive to house dust mites.
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2010
At a glance
- Drugs House dust mite allergy immunotherapy Laboratorios LETI (Primary)
- Indications Allergic asthma; Allergic rhinoconjunctivitis
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.